An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone on an online forum described trying to stretch out their Mounjaro injections and then hitting a rough patch of diarrhea. They started Mounjaro 2.5 mg on August 15 and stayed at that low dose because it seemed to be working. After a likely stomach bug the first week, the next week brought severe diarrhea again, so they skipped an injection and asked about dosing every two weeks instead of the usual schedule. Mounjaro is the brand name for tirzepatide. It’s a prescription injectable medicine originally approved to treat type 2 diabetes and now used off-label or in trials for weight loss. In plain terms, it acts like two gut hormones that tell your body to reduce appetite, slow how fast the stomach empties, and help control blood sugar. People who use it often report weight loss and changes in appetite and digestion. Because it’s a strong effect on digestion, side effects like nausea, vomiting, constipation, or diarrhea are common, especially when starting or changing doses. What this post shows is an individual’s experience, not a formal study. It’s an anecdote: one person having two bad weeks of diarrhea after starting a low dose and then skipping an injection. Anecdotes can highlight real issues but don’t tell us how common a problem is or whether changing the schedule helps. Clinical trials of tirzepatide report gastrointestinal side effects in many users, but those trials use controlled dosing schedules and monitoring. There isn’t reliable trial data showing that skipping doses or moving to biweekly (every-two-weeks) injections is safe or effective compared with the approved weekly schedule. Why it matters is practical. If you’re taking Mounjaro or considering it, digestive side effects are a common reason people stop or adjust their treatment. Knowing that others experience severe diarrhea could prompt you to talk to your prescriber about strategies: slower dose increases, temporary dose holds, anti-diarrheal medicines, diet adjustments, or switching medications. It also matters because changing the timing of injections can affect blood sugar control and the drug’s effectiveness. For people with diabetes, that could be risky. The main caveats: don’t change your dosing schedule without medical advice. Mounjaro is approved as a once-weekly injection; safety and effectiveness of other schedules aren’t established. Severe diarrhea can cause dehydration or electrolyte imbalances, and gastrointestinal symptoms can be caused by infections, other drugs, or the medication itself. If you have serious side effects, are pregnant, have pancreatitis history, or have other major health issues, you need to consult your clinician. Bottom line: this is a single-person story that highlights a real side effect, but it doesn’t prove that biweekly dosing is safe or helpful.
Source: r/Mounjaro